K-RAS 抗体
(GTPase Kras (KRAS))
This gene, a Kirsten ras oncogene homolog from the mammalian ras gene family, encodes a protein that is a member of the small GTPase superfamily. A single amino acid substitution is responsible for an activating mutation. The transforming protein that results is implicated in various malignancies, including lung adenocarcinoma, mucinous adenoma, ductal carcinoma of the pancreas and colorectal carcinoma. Alternative splicing leads to variants encoding two isoforms that differ in the C-terminal region. [provided by RefSeq, Jul 2008].
| Catalog no. | 产品 | 适用 | 宿主 / 克隆类型 | 应用 | 价格和交货时间 |
|---|---|---|---|---|---|
| K-RAS 抗体 (AA 25-130) (Cy5) | 人 | 兔 Polyclonal |
|
|
|
| K-RAS 抗体 (AA 25-130) (PE) | 人 | 兔 Polyclonal |
|
|
|
| K-RAS 抗体 (AA 25-130) (HRP) | 人 | 兔 Polyclonal |
|
|
|
| K-RAS 抗体 (AA 1-149) | 人 | 兔 Polyclonal |
|
|
|
| K-RAS 抗体 (AA 13-185) | 人 | 兔 Polyclonal |
|
|
|
| K-RAS 抗体 (AA 146-174) (PE) | 人, 小鼠 | 兔 Polyclonal |
|
|
|
| K-RAS 抗体 (AA 146-174) (APC) | 人, 小鼠 | 兔 Polyclonal |
|
|
|
| K-RAS 抗体 (AA 146-174) | 人, 小鼠 | 兔 Polyclonal |
|
|
|
| K-RAS 抗体 (C-Term) | 人, 大鼠, 小鼠 | 小鼠 Monoclonal |
|
|
|
| Recombinant K-RAS 抗体 (G12D) | 人 | 兔 Chimeric |
|
|
|
| Recombinant K-RAS 抗体 (G12D) | 人 | 小鼠 Monoclonal |
|
|
|
| K-RAS 抗体 (N-Term) | 人 | 兔 Polyclonal |
|
|
|
| K-RAS 抗体 (G12D) | 人 | 兔 Polyclonal |
|
|
|
| K-RAS 抗体 (Q61R) | 人 | 兔 Polyclonal |
|
|
|
| K-RAS 抗体 (A59T) | 人 | 兔 Polyclonal |
|
|
|
| K-RAS 抗体 (G12V) | 人 | 兔 Polyclonal |
|
|
|
| K-RAS 抗体 (G13D) | 人 | 兔 Polyclonal |
|
|
|
| K-RAS 抗体 (AA 2-168) (FITC) | 人 | 兔 Polyclonal |
|
|
|
| K-RAS 抗体 (AA 2-168) (Biotin) | 人 | 兔 Polyclonal |
|
|
|
| K-RAS 抗体 (AA 2-168) (HRP) | 人 | 兔 Polyclonal |
|
|
Primary Antibody
- WB (Western Blotting: 所列应用)
- FACS (Flow Cytometry: 所列应用)
- IF (cc) (Immunofluorescence (Cultured Cells): 所列应用)
- IF (p) (Immunofluorescence (Paraffin-embedded Sections): 所列应用)
- 适用
- 人
- 宿主
- 兔
- 克隆形成能力
- Polyclonal
- 标记
- Cy5
- 抗体亚型
- IgG
- 抗原表位
- AA 25-130
Primary Antibody
- WB (Western Blotting: 所列应用)
- FACS (Flow Cytometry: 所列应用)
- IF (cc) (Immunofluorescence (Cultured Cells): 所列应用)
- IF (p) (Immunofluorescence (Paraffin-embedded Sections): 所列应用)
- 适用
- 人
- 宿主
- 兔
- 克隆形成能力
- Polyclonal
- 标记
- PE
- 抗体亚型
- IgG
- 抗原表位
- AA 25-130
Primary Antibody
- WB (Western Blotting: 所列应用)
- IHC (p) (Immunohistochemistry (Paraffin-embedded Sections): 所列应用)
- IHC (fro) (Immunohistochemistry (Frozen Sections): 所列应用)
- 适用
- 人
- 宿主
- 兔
- 克隆形成能力
- Polyclonal
- 标记
- HRP
- 抗体亚型
- IgG
- 抗原表位
- AA 25-130
Primary Antibody
- WB (Western Blotting: 所列应用)
- ELISA (ELISA: 所列应用)
- IHC (Immunohistochemistry: 所列应用)
- 适用
- 人
- 宿主
- 兔
- 克隆形成能力
- Polyclonal
- 标记
- unconjugated
- 抗体亚型
- IgG
- 抗原表位
- AA 1-149
Primary Antibody
- WB (Western Blotting: 所列应用)
- ELISA (ELISA: 所列应用)
- IHC (Immunohistochemistry: 所列应用)
- 适用
- 人
- 宿主
- 兔
- 克隆形成能力
- Polyclonal
- 标记
- unconjugated
- 抗体亚型
- IgG
- 抗原表位
- AA 13-185
Primary Antibody
- WB (Western Blotting: 所列应用)
- ELISA (ELISA: 所列应用)
- IF (Immunofluorescence: 所列应用)
- FACS (Flow Cytometry: 所列应用)
- ICC (Immunocytochemistry: 所列应用)
- 适用
- 人, 小鼠
- 宿主
- 兔
- 克隆形成能力
- Polyclonal
- 标记
- PE
- 抗体亚型
- IgG
- 抗原表位
- AA 146-174
Primary Antibody
- WB (Western Blotting: 所列应用)
- ELISA (ELISA: 所列应用)
- IF (Immunofluorescence: 所列应用)
- FACS (Flow Cytometry: 所列应用)
- ICC (Immunocytochemistry: 所列应用)
- 适用
- 人, 小鼠
- 宿主
- 兔
- 克隆形成能力
- Polyclonal
- 标记
- APC
- 抗体亚型
- IgG
- 抗原表位
- AA 146-174
Primary Antibody
- WB (Western Blotting: 所列应用)
- ELISA (ELISA: 所列应用)
- IF (Immunofluorescence: 所列应用)
- FACS (Flow Cytometry: 所列应用)
- 适用
- 人, 小鼠
- 宿主
- 兔
- 克隆形成能力
- Polyclonal
- 标记
- unconjugated
- 抗体亚型
- IgG
- 抗原表位
- AA 146-174
Primary Antibody
- WB (Western Blotting: 所列应用)
- IHC (Immunohistochemistry: 所列应用)
- IF (Immunofluorescence: 所列应用)
- IP (Immunoprecipitation: 所列应用)
- IHC (p) (Immunohistochemistry (Paraffin-embedded Sections): 所列应用)
- 适用
- 人, 大鼠, 小鼠
- 宿主
- 小鼠
- 克隆形成能力
- Monoclonal
- 克隆
- 9-13
- 标记
- unconjugated
- 抗体亚型
- IgG1
- 抗原表位
- C-Term
Primary Antibody
- ELISA (ELISA: 所列应用)
- 适用
- 人
- 宿主
- 兔
- 克隆形成能力
- Chimeric
- 克隆
- D113
- 标记
- unconjugated
- 蛋白类型
- Recombinant Antibody
- 抗体亚型
- IgG, kappa
- 抗原表位
- G12D
Primary Antibody
- ELISA (ELISA: 所列应用)
- 适用
- 人
- 宿主
- 小鼠
- 克隆形成能力
- Monoclonal
- 克隆
- D113
- 标记
- unconjugated
- 蛋白类型
- Recombinant Antibody
- 抗体亚型
- IgG1, kappa
- 抗原表位
- G12D
Primary Antibody
- WB (Western Blotting: 所列应用)
- IHC (p) (Immunohistochemistry (Paraffin-embedded Sections): 所列应用)
- 适用
- 人
- 宿主
- 兔
- 克隆形成能力
- Polyclonal
- 标记
- unconjugated
- 抗体亚型
- IgG
- 抗原表位
- N-Term
Primary Antibody
- WB (Western Blotting: 所列应用)
- 适用
- 人
- 宿主
- 兔
- 克隆形成能力
- Polyclonal
- 标记
- unconjugated
- 抗体亚型
- IgG
- 抗原表位
- G12D
Primary Antibody
- WB (Western Blotting: 所列应用)
- 适用
- 人
- 宿主
- 兔
- 克隆形成能力
- Polyclonal
- 标记
- unconjugated
- 抗体亚型
- IgG
- 抗原表位
- Q61R
Primary Antibody
- WB (Western Blotting: 所列应用)
- 适用
- 人
- 宿主
- 兔
- 克隆形成能力
- Polyclonal
- 标记
- unconjugated
- 抗体亚型
- IgG
- 抗原表位
- A59T
Primary Antibody
- WB (Western Blotting: 所列应用)
- IF (Immunofluorescence: 所列应用)
- ICC (Immunocytochemistry: 所列应用)
- 适用
- 人
- 宿主
- 兔
- 克隆形成能力
- Polyclonal
- 标记
- unconjugated
- 抗体亚型
- IgG
- 抗原表位
- G12V
Primary Antibody
- WB (Western Blotting: 所列应用)
- 适用
- 人
- 宿主
- 兔
- 克隆形成能力
- Polyclonal
- 标记
- unconjugated
- 抗体亚型
- IgG
- 抗原表位
- G13D
Primary Antibody
- 适用
- 人
- 宿主
- 兔
- 克隆形成能力
- Polyclonal
- 标记
- FITC
- 抗体亚型
- IgG
- 抗原表位
- AA 2-168
Primary Antibody
- ELISA (ELISA: 所列应用)
- 适用
- 人
- 宿主
- 兔
- 克隆形成能力
- Polyclonal
- 标记
- Biotin
- 抗体亚型
- IgG
- 抗原表位
- AA 2-168
Primary Antibody
- ELISA (ELISA: 所列应用)
- 适用
- 人
- 宿主
- 兔
- 克隆形成能力
- Polyclonal
- 标记
- HRP
- 抗体亚型
- IgG
- 抗原表位
- AA 2-168
Latest Publications for our K-RAS 抗体
: "EPHA2 feedback activation limits the response to PDEδ inhibition in KRAS-dependent cancer cells." in: Acta pharmacologica Sinica, Vol. 41, Issue 2, pp. 270-277, (2020) (PubMed).
: "Upregulation of long noncoding RNA CCAT1-L promotes epithelial-mesenchymal transition in gastric adenocarcinoma." in: OncoTargets and therapy, Vol. 11, pp. 5647-5655, (2018) (PubMed).
: "Cell surface protease activation during RAS transformation: Critical role of the plasminogen receptor, S100A10." in: Oncotarget, Vol. 7, Issue 30, pp. 47720-47737, (2016) (PubMed).
: "Evidence for aldosterone-dependent growth of renal cell carcinoma." in: International journal of experimental pathology, Vol. 95, Issue 4, pp. 244-50, (2014) (PubMed).
: "Overexpression of DDX43 mediates MEK inhibitor resistance through RAS Upregulation in uveal melanoma cells." in: Molecular cancer therapeutics, Vol. 13, Issue 8, pp. 2073-80, (2014) (PubMed).
: "KRAS gene amplification in colorectal cancer and impact on response to EGFR-targeted therapy. ..." in: International journal of cancer. Journal international du cancer, Vol. 133, Issue 5, pp. 1259-65, (2013) (PubMed).
: "4-Hydroxytamoxifen induces autophagic death through K-Ras degradation." in: Cancer research, Vol. 73, Issue 14, pp. 4395-405, (2013) (PubMed).
: "Synergistic effects of combined Wnt/KRAS inhibition in colorectal cancer cells." in: PLoS ONE, Vol. 7, Issue 12, pp. e51449, (2012) (PubMed).
: "Analysis of k-ras nuclear expression in fibroblasts and mesangial cells." in: PLoS ONE, Vol. 5, Issue 1, pp. e8703, (2010) (PubMed).
: "p66(Shc) restrains Ras hyperactivation and suppresses metastatic behavior." in: Oncogene, Vol. 29, Issue 41, pp. 5559-67, (2010) (PubMed).
: "Upregulation of long noncoding RNA CCAT1-L promotes epithelial-mesenchymal transition in gastric adenocarcinoma." in: OncoTargets and therapy, Vol. 11, pp. 5647-5655, (2018) (PubMed).
: "Cell surface protease activation during RAS transformation: Critical role of the plasminogen receptor, S100A10." in: Oncotarget, Vol. 7, Issue 30, pp. 47720-47737, (2016) (PubMed).
: "Evidence for aldosterone-dependent growth of renal cell carcinoma." in: International journal of experimental pathology, Vol. 95, Issue 4, pp. 244-50, (2014) (PubMed).
: "Overexpression of DDX43 mediates MEK inhibitor resistance through RAS Upregulation in uveal melanoma cells." in: Molecular cancer therapeutics, Vol. 13, Issue 8, pp. 2073-80, (2014) (PubMed).
: "KRAS gene amplification in colorectal cancer and impact on response to EGFR-targeted therapy. ..." in: International journal of cancer. Journal international du cancer, Vol. 133, Issue 5, pp. 1259-65, (2013) (PubMed).
: "4-Hydroxytamoxifen induces autophagic death through K-Ras degradation." in: Cancer research, Vol. 73, Issue 14, pp. 4395-405, (2013) (PubMed).
: "Synergistic effects of combined Wnt/KRAS inhibition in colorectal cancer cells." in: PLoS ONE, Vol. 7, Issue 12, pp. e51449, (2012) (PubMed).
: "Analysis of k-ras nuclear expression in fibroblasts and mesangial cells." in: PLoS ONE, Vol. 5, Issue 1, pp. e8703, (2010) (PubMed).
: "p66(Shc) restrains Ras hyperactivation and suppresses metastatic behavior." in: Oncogene, Vol. 29, Issue 41, pp. 5559-67, (2010) (PubMed).
Aliases for K-RAS 抗体
KRAS proto-oncogene, GTPase (KRAS) 抗体v-Ki-ras2 Kirsten rat sarcoma viral oncogene homolog (kras) 抗体
KRAS proto-oncogene, GTPase (Kras) 抗体
Kirsten rat sarcoma viral oncogene homolog (Kras) 抗体
semicolonial-7 (smco-7) 抗体
Ras family protein (PGTG_03066) 抗体
GTPase KRas (Tsp_02666) 抗体
GTPase KRas (Tsp_01642) 抗体
GTPase KRas (rask) 抗体
Kirsten rat sarcoma viral oncogene homolog S homeolog (kras.S) 抗体
AI929937 抗体
C-K-RAS 抗体
c-Ki-ras 抗体
CFC2 抗体
K-ras 抗体
k-ras 抗体
K-RAS 抗体
K-RAS2A 抗体
K-RAS2B 抗体
K-RAS4A 抗体
K-RAS4B 抗体
KI-RAS 抗体
Ki-ras 抗体
kras 抗体
Kras-2 抗体
kras-a 抗体
kras-b 抗体
KRAS1 抗体
Kras2 抗体
KRAS2 抗体
NS 抗体
NS3 抗体
p21 抗体
p21B 抗体
p21ras 抗体
ras 抗体
RASK2 抗体
rask2 抗体
wu:fa04e08 抗体
wu:fc14b12 抗体
wu:fc23g10 抗体
wu:fj89d12 抗体
zgc:85725 抗体
您还需要查找其他产品吗？
You are here:
